Home > SWOT Analysis > Eli Lilly (LLY) SWOT Analysis

Eli Lilly (LLY) SWOT Analysis Profile

Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide, including medications for schizophrenia, bipolar mania, depression, attention-deficit hyperactivity disorder, obsessive-compulsive disorder; Parkinsons disease, diabetes, osteoporosis, various cancers, and more. The company also develops and sells animal health products, medications, and antibiotics. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 4

Threats + Weaknesses = 2

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties. Maintaining strengths can help maintain high profits and low costs.